How to Integrate Dermal Matrices into Your Reconstructive Surgical Practice

Watch On Demand

In this video, Dr. Stephen J. Kovach, Herndon B. Lehr Endowed Associate Professor of Surgery and Associate Professor in Division of Plastic Surgery and Department of Orthopaedic Surgery at the University of Pennsylvania Health System, discusses his algorithm for approaching soft tissue coverage in a variety of cases.

He presents 5 trauma cases and 2 oncological wounds in the lower extremities, and talks through his considerations for when he used Integra Bilayer Wound Matrix (IBWM), free flap and local tissue transfer.

Pictured: Chronic non-healing wound managed with IBWM; rupture and repair wound before and after free flap; and degloved knee and tibia fracture treated with local flap

“You have a lot of tools at your disposal,” he says. “I think the reconstructive elevator tells you, ‘do the operation that’s going to have the highest chance of succeeding, with the least amount of morbidity to the patient in the most efficient and economic means that you can.’”

INDICATIONS: Integra® Bilayer Wound Matrix is indicated for the management of wounds including: partial- and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, surgical wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns and skin tears) and draining wounds. The device is intended for one-time use.

CONTRAINDICATIONS: This device should not be used in patients with known sensitivity to bovine collagen or chondroitin materials. This device is not indicated for use in third-degree burns.

PRECAUTIONS:

  • Do not resterilize. Discard all opened and unused portions of Integra Bilayer Wound Matrix.
  • Device is sterile if the package is unopened and undamaged. Do not use if the package seal is broken.
  • Discard device if mishandling has caused possible damage or contamination.
  • Integra Bilayer Matrix Wound Dressing should not be applied until excessive exudate, bleeding, acute swelling and infection are controlled.
  • Debridement or excision must be done thoroughly to remove any remaining necrotic tissue that may cause infection.
  • The following complications are possible with the use of wound dressings. If any of the conditions occur, the device should be removed: infection, chronic inflammation (initial application of wound dressings may be associated with transient, mild, localized inflammation), allergic reaction, excessive redness, pain or swelling.

Please fill out the below form to access this premium content:


    By submitting this form, you agree to our Privacy Policy and Terms of Use.

    How to Integrate Dermal Matrices into Your Reconstructive Surgical Practice

    Watch On Demand

    While welding a large metal pipe, a 35-year-old male caught his foot between pipe plates, causing a 15-minute contact burn to his leg.

    Dr. Rohit Mittal, assistant professor of surgery at Emory School of Medicine and the Director of the Burn Reconstruction Program at Grady Burn Center, saw him one week after injury. His wounds had exposed bone, tendons and nerves.

    Instead of using two free flaps to cover both sides of the patient’s leg, Dr. Mittal decided to try the dermal scaffold, PriMatrix.

    The patient then received a skin graft on day 42 and is now able to walk with the aid of an orthotic.

    Watch this case-specific webinar to learn:

      • How often Dr. Mittal debrided the wound before applying PriMatrix
      • His dressing changing protocol once PriMatrix was applied
      • His approach to non-viable sections of the patient’s fibula

    Please fill out the below form to access this premium content:


      By submitting this form, you agree to our Privacy Policy and Terms of Use.

      INDICATIONS: Integra® Bilayer Wound Matrix is indicated for the management of wounds including: partial- and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, surgical wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns and skin tears) and draining wounds. The device is intended for one-time use.

      CONTRAINDICATIONS: This device should not be used in patients with known sensitivity to bovine collagen or chondroitin materials. This device is not indicated for use in third-degree burns.

      PRECAUTIONS:

      • Do not resterilize. Discard all opened and unused portions of Integra Bilayer Wound Matrix.
      • Device is sterile if the package is unopened and undamaged. Do not use if the package seal is broken.
      • Discard device if mishandling has caused possible damage or contamination.
      • Integra Bilayer Matrix Wound Dressing should not be applied until excessive exudate, bleeding, acute swelling and infection are controlled.
      • Debridement or excision must be done thoroughly to remove any remaining necrotic tissue that may cause infection.
      • The following complications are possible with the use of wound dressings. If any of the conditions occur, the device should be removed: infection, chronic inflammation (initial application of wound dressings may be associated with transient, mild, localized inflammation), allergic reaction, excessive redness, pain or swelling.
      Share via
      Copy link
      Powered by Social Snap